20 results
6-K
EX-1.1
TLSA
Tiziana Life Sciences Ltd
1 Sep 23
Report of Foreign Private Issuer
4:46pm
, packaging, processing, use, distribution, marketing, labeling, promotion, sale, offer for sale, storage, import, export or disposal of any product under
6-K
EX-99.1
TLSA
Tiziana Life Sciences Ltd
30 Sep 20
Interim Results for the Six Months Ended 30 June 2020
6:11am
, packaging and ICH stability studies in Q1 2021.
In July 2020, Tiziana engaged FHI clinical as CRO to conduct Phase1/2 clinical trials of TZLS-501
6-K
EX-10.2
nfaj cj4yo
4 Aug 20
This Announcement Contains Inside Information for the Purposes of Article 7 of Regulation (Eu) No 596/2014
4:26pm
6-K
EX-1.1
9a3 ge3ex
14 Apr 20
Current report (foreign)
8:46am
F-1/A
g5ya1elplrh9uk87
20 Sep 19
Registration statement (foreign) (amended)
4:51pm
F-1/A
9smz idsvzc6ulyf
17 Sep 19
Registration statement (foreign) (amended)
5:19pm
F-1
vz3hrkybpo0uh2
5 Aug 19
Registration statement (foreign)
4:28pm
DRS
4q8q3 hs4ft7o1
17 Jul 19
Draft registration statement
12:00am
20-F
sydgbaf9
4 Apr 19
Annual report (foreign)
6:07am
424B4
ls4w t6ru
21 Nov 18
Prospectus supplement with pricing info
6:10am
POS AM
18rqu9xll3 tsmho1
14 Nov 18
Prospectus update (post-effective amendment)
12:00am
F-1/A
1ias5ohgto7yfc4
30 Oct 18
Registration statement (foreign) (amended)
12:00am
F-1/A
zmw2dpdm270
23 Oct 18
Registration statement (foreign) (amended)
1:04pm
F-1/A
q9jp3 tcrbcy2whyvwi
17 Oct 18
Registration statement (foreign) (amended)
8:40pm
F-1
q28f1mszv0wxm19zl
26 Jul 18
Registration statement (foreign)
5:06pm
DRS/A
ag0394l
10 May 18
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next